My ePortfolio Register   

WIN Symposium 2017 /
Proteogenomics in cancer research

26th - 27th Jun 2017

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 04.07.17
Views: 345
Rating:

Dr Henry Rodriguez - National Cancer Institute (NIH), Bethesda, USA

Dr Rodriguez speaks with ecancer at WIN 2017 about the translation of the proteins expressed in a patient's tumour into a map for druggable targets.

He highlights aspects of the Beau Biden Cancer Moonshot initiative, working with the National Cancer Institute, which aim to open global access to data libraries of tumour genomics and proteomics, including the APOLLO program and the International Cancer Proteogenome Consortium.

 

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence